🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to monitor safety outcomes for patients being ...
Status
Unknown
Location
Southeast Retina
Start Date
2013-03
Trial ID
NCT01790893
Treatments Being Tested
This is an observational study to collect data from Japanese babies with re...
Status
Active Not Recruiting
Location
Many locations
Start Date
2023-03-27
Trial ID
NCT05705258
Treatments Being Tested
The Endurance Trial is a phase IV open label clinical study to assess the n...
Status
Completed
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT02297204
Treatments Being Tested
The treatment landscape for neovascular AMD has evolved with various anti-V...
Status
Completed
Location
Kim's Eye Hospital
Start Date
2024-10-21
Trial ID
NCT06683950
Treatments Being Tested
This study aims to evaluate the optimal use, efficacy, and safety of a Trea...
Status
Completed
Location
Multiple Locations
Start Date
2015-11-19
Trial ID
NCT02581891
Comparison of efficacy and safety of Mitomycin and Aflibercept used to supp...
Status
Completed
Location
Medical University of Lublin
Start Date
2017-06-14
Trial ID
NCT03766425
Treatments Being Tested
Phase 2 open label, randomized, active controlled, dose-ranging trial in ad...
Status
Recruiting
Location
Sierra Eye Associates
Start Date
2025-03-18
Trial ID
NCT06942520
Treatments Being Tested
The purpose of this study is to compare brolucizumab (RTH258) ophthalmic so...
Status
Completed
Location
Contact Alcon Call Center for Trial Locations
Start Date
2014-12-08
Trial ID
NCT02307682
Treatments Being Tested
Goals of the study are to evaluate how peri-operative versus intra-operativ...
Status
Withdrawn
Location
Emory Clinic
Start Date
2020-05
Trial ID
NCT03920878
Treatments Being Tested
The main goal is to study way that aflibercept injection behaves in the eye...
Status
Completed
Location
University of Nebraska Medical Center, Truhlsen Eye Institute
Start Date
2014-09-05
Trial ID
NCT02204683
Treatments Being Tested